DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Effects of Mode of Administration of Soluble Fibre Blend on Glycemia, Appetite & Sensory Parameters

Information source: St. Michael's Hospital, Toronto
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Healthy

Intervention: Soluble viscous fibre blend powder in hydrophobic matrix (Dietary Supplement); Soluble viscous fibre blend in pre hydrated form (Dietary Supplement); No soluble viscous fibre blend (Dietary Supplement); Soluble viscous fibre blend premixed with ½ carbohydrate gel (Dietary Supplement); No soluble viscous fibre blend, ½ carbohydrate jello (Dietary Supplement)

Phase: Phase 1/Phase 2

Status: Active, not recruiting

Sponsored by: St. Michael's Hospital, Toronto

Official(s) and/or principal investigator(s):
Vladimir Vuksan, Principal Investigator, Affiliation: St. Michael's Hospital, Toronto


Soluble, viscous fibre has been established as an effective dietary component for lowering postprandial glycemia and promoting satiety. The effectiveness of viscous fibre has been related to its ability to increase the viscosity of the intra-luminal contents of the small intestine. Hence, the proposed mechanism with which soluble fibre affects the glycemic response, dependent on the viscosity development in the gut, would require that soluble fibre be extractable from the food matrix. This, in part, may be dependent on the food matrix that the soluble fibre is incorporated in. While properties of soluble fibre and their physiological effects have been studied extensively, limited data exists on the most effective mode of administration of fibre to optimize benefits. Furthermore, there are no studies to date that have evaluated how different modes of highly viscous soluble fibre would affect the subsequent meal. Hence, we propose a research study to determine whether the form of administration, taking into consideration the carbohydrate availability of a viscous fibre blend supplement, has a significant impact on postprandial and second meal glycemic response and subjective satiety in healthy individuals.

Clinical Details

Official title: The Effects of Different Modes of Administration of Soluble Fibre on Postprandial and Second Meal Blood Glucose Response, Appetite and Sensory Parameters in Healthy Individuals

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Primary outcome: Postprandial glycemia

Secondary outcome:


Second Meal Glycemia


Detailed description: Following a 10-12 hr overnight fast, subjects will visit the Risk Factor Modification Centre between 8: 00 am and 1: 00 pm. Blood pressure and anthropometric measurements, including body weight, height, and % body fat will be taken. An initial finger prick fasting blood sample will be taken and a subjective appetite questionnaire in the form of a 100 mm visual analog scale will be completed. Subsequently, one of the 5 study meals will be administered to the subject to consume over a 10-15 minute duration accompanied by 300ml of water. Subjects will then be asked to complete a palatability questionnaire. Over the following 3 hours capillary blood samples will be taken by finger pricks at 15, 30, 45, 60, 90, 120 and 180 minutes post treatment. Appetite and symptoms questionnaires will be completed at 15, 30, 45, 60, 75, 90, and 120. At 180 min, a second standardized meal will be administered, consisting of 400kcal of pizza and 200ml of water. Further finger pick blood samples will be taken at 15, 30, 45, 60 and 120 min post pizza consumption. Upon completion of the visit, subjects will be given a 24-hour symptoms questionnaire to complete at home as an additional safety measure for a 24-hour period.


Minimum age: 18 Years. Maximum age: 65 Years. Gender(s): Both.


Inclusion Criteria:

- age 18-65 years

- normal glycemic response

- BMI between 18. 5 - 25 kg/m2

- peripheral systolic and diastolic blood pressure <140 mmHg and <90 mmHg,

respectively. Exclusion Criteria:

- Known reported history of liver or kidney disease, diabetes, hypertension, stroke or

myocardial infarctions, thyroid disease, Celiac disease/gastrointestinal disease, or AIDS

- allergies to any of the test products

- Presence of an eating disorder

- Following a restrictive dieting regime

- Weight loss of >5kg in last 2 months

- Smoking cigarettes

- Alcohol intake >2 drinks/day

- using prescription medications or Natural Health Products;

- any condition which, in the opinion of the investigator might jeopardize the health

and safety of the subject or study personnel, or adversely affect the study results

Locations and Contacts

St.Michael's Hospital, Toronto, Ontario, Canada
Additional Information

Starting date: July 2012
Last updated: March 6, 2014

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017